{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:25:44Z","timestamp":1783074344170,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jcms.2016.07.026","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T13:43:11Z","timestamp":1470231791000},"page":"1689-1693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid \u2013 A prospective study over 6 years"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-1277","authenticated-orcid":false,"given":"Thomas","family":"M\u00fccke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Deppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Dietrich","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco R.","family":"Kesting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta","family":"Retz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen E.","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Thalgott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2016.07.026_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10006-005-0670-0","article-title":"Bisphosphonate-associated osteonecrosis of the jaw","volume":"10","author":"Abu-Id","year":"2006","journal-title":"Mund Kiefer Gesichtschir"},{"key":"10.1016\/j.jcms.2016.07.026_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib3","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","article-title":"Natural history of osteonecrosis of the jaw in patients with multiple myeloma","volume":"26","author":"Badros","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib4","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcms.2015.02.018","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction","volume":"43","author":"Bodem","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib6","first-page":"b147","article-title":"Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients","volume":"77","author":"Bonacina","year":"2011","journal-title":"J\u00a0Can Dent Assoc"},{"key":"10.1016\/j.jcms.2016.07.026_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","volume":"44","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib8","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.bjc.6601437","article-title":"Bone resorption predicts for skeletal complications in metastatic bone disease","volume":"89","author":"Brown","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcms.2016.07.026_bib9","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2016.07.026_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0305-7372(03)00071-9","article-title":"Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment","volume":"29","author":"Eaton","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jcms.2016.07.026_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3959(98)00135-3","article-title":"The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials","volume":"78","author":"Fulfaro","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.jcms.2016.07.026_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0093-7754(03)00347-6","article-title":"Role of bisphosphonates in prostate cancer bone metastases","volume":"30","author":"Guise","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib14","first-page":"103","article-title":"Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer","volume":"22","author":"Hagiwara","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jcms.2016.07.026_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jcms.2016.07.026_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2016.07.026_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1600-051X.1984.tb01317.x","article-title":"Evaluation of cause-related periodontal therapy and compliance with maintenance care recommendations","volume":"11","author":"Johansson","year":"1984","journal-title":"J\u00a0Clin Periodontol"},{"key":"10.1016\/j.jcms.2016.07.026_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/bjc.2014.311","article-title":"Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment","volume":"111","author":"Kluth","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcms.2016.07.026_bib19","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib20","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00784-011-0596-x","article-title":"Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap","volume":"16","author":"Lemound","year":"2012","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.jcms.2016.07.026_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cncr.11571","article-title":"Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma","volume":"98","author":"Lipton","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2016.07.026_bib22","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphanates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper","volume":"136","author":"Migliorati","year":"2005","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jcms.2016.07.026_bib24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00432-010-0953-1","article-title":"Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"137","author":"M\u00fccke","year":"2011","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jcms.2015.12.017","article-title":"The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"44","author":"M\u00fccke","year":"2016","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib26","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","article-title":"Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?","volume":"68","author":"Otto","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib27","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","article-title":"Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism","volume":"68","author":"Otto","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development?","volume":"43","author":"Otto","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","article-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan","volume":"20","author":"Ripamonti","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00432-014-1588-4","article-title":"Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?","volume":"140","author":"Ristow","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.pcan.4500752","article-title":"Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients","volume":"7","author":"Rodrigues","year":"2004","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jcms.2016.07.026_bib33","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcms.2016.07.026_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-642-21892-7_5","article-title":"Bisphosphonates: prevention of bone metastases in prostate cancer","volume":"192","author":"Saad","year":"2012","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.jcms.2016.07.026_bib36","first-page":"449","article-title":"Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up","volume":"18","author":"Stockmann","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jcms.2016.07.026_bib37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00432-013-1377-5","article-title":"Detection of circulating tumor cells in different stages of prostate cancer","volume":"139","author":"Thalgott","year":"2013","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jcms.2016.07.026_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.joms.2007.11.025","article-title":"Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws","volume":"66","author":"Vescovi","year":"2008","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","article-title":"Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate","volume":"54","author":"Walter","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.jcms.2016.07.026_bib40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","article-title":"Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy","volume":"65","author":"Wang","year":"2007","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2016.07.026_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.critrevonc.2006.12.005","article-title":"Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients \u2013 May 2006","volume":"62","author":"Weitzman","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jcms.2016.07.026_bib43","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/jnci\/djm029","article-title":"Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions","volume":"99","author":"Woo","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcms.2016.07.026_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518216301603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518216301603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:35:10Z","timestamp":1760884510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518216301603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1010518216301603"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2016.07.026","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid \u2013 A prospective study over 6 years","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2016.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}